These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25537131)

  • 21. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin.
    Manglik A; Kobilka B
    Curr Opin Cell Biol; 2014 Apr; 27():136-43. PubMed ID: 24534489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biased Signaling of the G-Protein-Coupled Receptor β
    Lamichhane R; Liu JJ; White KL; Katritch V; Stevens RC; Wüthrich K; Millar DP
    Structure; 2020 Mar; 28(3):371-377.e3. PubMed ID: 31978323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
    Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
    Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent progress in understanding of structure, ligand interactions and the mechanism of activation of the β₂-adrenergic receptor.
    Kolinski M; Plazinska A; Jozwiak K
    Curr Med Chem; 2012; 19(8):1155-63. PubMed ID: 22300047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.
    Magnan R; Escrieut C; Gigoux V; De K; Clerc P; Niu F; Azema J; Masri B; Cordomi A; Baltas M; Tikhonova IG; Fourmy D
    J Am Chem Soc; 2013 Feb; 135(7):2560-73. PubMed ID: 23323542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
    Hudson BD; Hébert TE; Kelly ME
    Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional selectivity of G-protein-coupled receptors: from recombinant systems to native human cells.
    Seifert R
    Biochem Pharmacol; 2013 Oct; 86(7):853-61. PubMed ID: 23933388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
    Reynolds KA; Katritch V; Abagyan R
    J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
    Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
    Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
    Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How ligands and signalling proteins affect G-protein-coupled receptors' conformational landscape.
    Mary S; Fehrentz JA; Damian M; Verdié P; Martinez J; Marie J; Banères JL
    Biochem Soc Trans; 2013 Feb; 41(1):144-7. PubMed ID: 23356274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational biosensors reveal GPCR signalling from endosomes.
    Irannejad R; Tomshine JC; Tomshine JR; Chevalier M; Mahoney JP; Steyaert J; Rasmussen SG; Sunahara RK; El-Samad H; Huang B; von Zastrow M
    Nature; 2013 Mar; 495(7442):534-8. PubMed ID: 23515162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy.
    van der Westhuizen ET; Breton B; Christopoulos A; Bouvier M
    Mol Pharmacol; 2014 Mar; 85(3):492-509. PubMed ID: 24366668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional selectivity and classical concepts of quantitative pharmacology.
    Urban JD; Clarke WP; von Zastrow M; Nichols DE; Kobilka B; Weinstein H; Javitch JA; Roth BL; Christopoulos A; Sexton PM; Miller KJ; Spedding M; Mailman RB
    J Pharmacol Exp Ther; 2007 Jan; 320(1):1-13. PubMed ID: 16803859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells.
    Fang Y; Ferrie AM
    FEBS Lett; 2008 Mar; 582(5):558-64. PubMed ID: 18242178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural equilibrium underlying ligand-dependent activation of β
    Imai S; Yokomizo T; Kofuku Y; Shiraishi Y; Ueda T; Shimada I
    Nat Chem Biol; 2020 Apr; 16(4):430-439. PubMed ID: 31959965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.